India's share in the global contract research and synthesis of molecules is increasing rapidly. The Indian pharmaceutical industry is advancing in terms of knowledge. It has competitive capabilities to increase its share in the global contract research sector. A few forward-looking players have capabilities in process research, have a requisite infrastructure and are investing time and resources in developing the custom synthesis business, servicing the requirement of the early stage compounds in the UK and Europe. |